About Products Technology Investors News Contact Us Best Medicines for our Best Friends A subsidiary of Elanco Animal Health, Inc. About Strategy and industry leadership. Pipeline Deep pipeline of innovative biologics in development Education Videos, clinical studies, and continuing education. Keep up with KindredBio news on social media! © Copyright 2012-2020 | Kindred Biosciences, Inc. Terms of Use | Privacy Policy | Contact Us

About Products Technology Investors News Contact Us KindredBio has an exciting pipeline of high-value biologic candidates for dogs and cats in development. Pipeline Snapshot KIND-030 – Parvovirus in dogs Tirnovetmab (IL31 Antibody) – Atopic dermatitis in dogs Long-acting IL-31 antibody – Atopic dermatitis in dogs Anti-TNFα Antibody – Inflammatory bowel disease in dogs IL4R Antibody – Atopic dermatitis in dogs Other pipeline candidates in development (partial list) include KIND-bodies, IgE antibody, CD20 antibody, VEGF antibody, and Checkpoint Inhibitors. Pipeline Disclaimer: This material is intended to provide investors with information about KindredBio’s clinical development pipeline and is not intended for promotional purposes. Our dogs look to us. Dogs suffer from many of the same diseases that humans do, including allergic, inflammatory, and autoimmune diseases, as well as cancer. We have a deep pipeline of innovative biologics in development specifically for dogs, their owners, and the veterinarians that care for them. Visit Canine Pipeline US-CORP-1900168 FEB-20 Learn more about the KindredBio leadership team Learn More NEWS Elanco Announces Agreement to Acquire Kindred Biosciences June 16, 2021 - 6:57 am Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus June 2, 2021 - 8:45 am Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI May 25, 2021 - 8:57 am EVENTS Event: Kindred Biosciences to Present at the LD Micro Invitational XI May 25, 2021 - 9:14 am Event: Kindred Biosciences to Present at the Stifel 2021 Virtual Jaws & Paws Conference May 25, 2021 - 9:12 am Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results March 8, 2021 - 8:48 am Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements © Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010